e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical issues in granulomatous lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rescue administration of cyclophosphamide in patients with DAH - retrospective evaluation and outcome from our ICU
J. Blažek (Pilsen, Czech Republic), O. Kirchnerová (Pilsen, Czech Republic), D. Havel (Pilsen, Czech Republic), J. Klaboch (Pilsen, Czech Republic), J. Baxa (Pilsen, Czech Republic), P. Molácková (Pilsen, Czech Republic)
Source:
Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Session:
Clinical issues in granulomatous lung diseases
Session type:
E-poster session
Number:
3014
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Blažek (Pilsen, Czech Republic), O. Kirchnerová (Pilsen, Czech Republic), D. Havel (Pilsen, Czech Republic), J. Klaboch (Pilsen, Czech Republic), J. Baxa (Pilsen, Czech Republic), P. Molácková (Pilsen, Czech Republic). Rescue administration of cyclophosphamide in patients with DAH - retrospective evaluation and outcome from our ICU. 3014
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Pegfilgrastim drastically lowered risk of febrile neutropenia in Japanese patients with thoracic malignancy receiving chemotherapy - a retrospective single institutional study
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Use of corticosteroids in patients with severe CAP admitted to ICU, experience in a real-life setting.
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004
Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021
Safety and efficacy of outpatient bronchoscopy in lung transplant recipients: A single centre retrospective analysis
Source: Annual Congress 2011 - The basic and the future: pure diagnostic or dedicated wavelengths play
Year: 2011
Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020
Year: 2021
Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021
Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Source: Eur Respir J, 56 (6) 2002808; 10.1183/13993003.02808-2020
Year: 2020
A retrospective study of antibiotic prescribing for patients admitted to hospital with exacerbation of COPD
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018
Hemoptysis; etiology and outcomes in a university hospital – retrospective evaluation of 132 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 394s
Year: 2006
A retrospective analysis of methotrexate therapy as a steroid sparing agent within a UK severe asthma clinic
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012
Evaluation of cancer patients admitted to a respiratory intensive care unit: a retrospective analysis
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009
Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Late Breaking Abstract - Corticosteroids reduce mortality and prevent ICU admission in Covid-19 pneumonia – results from a rapid clinical review of 191 patients
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept